Clinical Trial Results:
A six-month, prospective, multicenter, open label, parallel, randomized study of the safety, tolerability and efficacy of myfortic® (ERL080) with Simulect®, corticosteroids and two different levels of tacrolimus in de novo renal transplant recipients
Summary
|
|
EudraCT number |
2005-001518-42 |
Trial protocol |
ES GB IT |
Global completion date |
26 Mar 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Mar 2017
|
First version publication date |
04 Mar 2017
|
Other versions |
|
Summary report(s) |
CERL080A2409 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.